Skip to search formSkip to main contentSkip to account menu

naratriptan

Known as: naratriptan [Chemical/Ingredient], N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide, N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by the expansion of the CAG triplet repeat within the… 
Highly Cited
2004
Highly Cited
2004
Objective.—To assess the reasons for switching triptans within migraine patients presenting to a specialty clinic. 
2004
2004
Objective.—To provide medication price data and cost‐reducing strategies for the acute treatment of migraine. 
2003
2003
Objective.—To describe the demographics and migraine characteristics of patients in the Glaxo Wellcome adolescent clinical trials… 
2001
2001
AbstractPurpose. The overall aim of the present study was to investigate retrospectively the feasibility and utility of model… 
Highly Cited
2000
Highly Cited
2000
Development of a rapid, sensitive and selective method for the determination of antimigraine drugs from human serum is essential… 
1999
1999
To the Editor: The publication on the efficacy of the new second-generation 5-hydroxytryptamine (5HT)1B/1D agonist naratriptan…